Related Experiment Video
Updated: Sep 7, 2025

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Clinical Update in Women's Heart Disease
1Division of General Internal Medicine, Brown University, Narragansett, Rhode Island, USA.
Insights
Recent findings highlight new cardiovascular disease (CVD) risk factors in women, including breastfeeding benefits and migraine with aura. Updated risk assessment tools and mammography markers can improve CVD prediction and prevention in primary care.
Area of Science:
- Cardiology
- Women's Health
- Preventive Medicine
Background:
- Cardiovascular disease (CVD) remains a leading cause of mortality in women.
- Primary care practitioners require updated evidence to optimize women's cardiovascular health.
- Recent literature offers new insights into CVD prevention, risk assessment, and diagnosis.
Purpose of the Study:
- To identify recent literature that may alter clinical practice regarding cardiovascular disease in women.
- To provide a clinical update on the prevention, risk assessment, and diagnosis of CVD in women for primary care settings.
Main Methods:
- Review of high-impact medical and women's health journals.
- Inclusion of national guidelines, ACP JournalWise, and NEJM Journal Watch.
- Selection of recent publications relevant to cardiovascular disease in women.
Main Results:
- Breastfeeding demonstrates a significant reduction in subsequent CVD.
- Migraine with aura, and severe early- and late-onset hot flashes are identified as CVD risk factors.
- New data support the use of CVD risk scores over traditional metrics (age, years since menopause) for predicting risk.
- Breast arterial calcification on mammography shows promise as a noninvasive CVD risk marker.
Conclusions:
- Clinical practice regarding women's cardiovascular health can be updated with recent findings.
- Incorporating updated risk assessment tools and recognizing novel risk factors can enhance CVD prediction.
- Mammography markers may improve noninvasive CVD risk stratification in women.
Abstract:
The goal in selecting these recent articles was to help identify literature that may change the clinical practice of women's health for practitioners in the primary care setting. Articles were identified by reviewing high-impact medical and women's health journals, national guidelines, ACP JournalWise, and NEJM Journal Watch. In this clinical update, we selected recent publications relevant to the prevention, risk assessment, and diagnosis of cardiovascular disease (CVD) in women. Breastfeeding now has data suggesting a robust reduction in subsequent CVD, and migraine with aura and severe and early- and late-onset hot flashes can now be considered risk factors for CVD. The decision to initiate menopausal hormone therapy is influenced by estimation of underlying vascular risk, and new data suggest that CVD risk scores are more accurate in predicting CVD risk than the traditionally used age and years since menopause and should be incorporated into counseling. Finally, new data support the growing belief that breast arterial calcification on mammography is a promising noninvasive marker that can enhance CVD risk prediction in women.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Heart Failure III: Clinical Manifestations
Rheumatic Heart Disease III: Medical Management